Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Akdas

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
British Journal of Urology|May 1, 1987
Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levelsM U Altug, A Akdas, S Ruacan, et al.
European Urology|January 1, 1996
The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/mlA Akdas, T Tarcan, L Türkeri, et al.
The Prostate|January 1, 1994
Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostateS Yenice, A T Davis, S A Goueli, et al.
Progress in Clinical and Biological Research|January 1, 1990
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical studyA Ersev, D Ersev, L Turkeri, et al.
British Journal of Urology|March 1, 1997
Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancerM Caliskan, L N Türkeri, B Mansuroglu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Adjuvant chemotherapy following radical radiotherapy in T3 bladder carcinomaB Richards, A Akdas, P Crobett, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1983
An EORTC phase II study of vindesine in advanced prostate cancerW G Jones, S D Fosså, L Denis, et al.
Acta Urologica Belgica|January 1, 1980
Hormone therapy in prostatic cancerP H Smith, A Akdas, M K Mason, et al.
British Journal of Urology|October 1, 1982
Bacteraemia resulting from prostatic surgery: the source of bacteriaM R Robinson, S T Arudpragasam, S M Sahgal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials GroupG Stoter, A Akdas, S D Fosså, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
British Journal of Urology|May 1, 1987
Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levelsM U Altug, A Akdas, S Ruacan, et al.
European Urology|January 1, 1996
The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/mlA Akdas, T Tarcan, L Türkeri, et al.
The Prostate|January 1, 1994
Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostateS Yenice, A T Davis, S A Goueli, et al.
Progress in Clinical and Biological Research|January 1, 1990
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical studyA Ersev, D Ersev, L Turkeri, et al.
British Journal of Urology|March 1, 1997
Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancerM Caliskan, L N Türkeri, B Mansuroglu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Adjuvant chemotherapy following radical radiotherapy in T3 bladder carcinomaB Richards, A Akdas, P Crobett, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1983
An EORTC phase II study of vindesine in advanced prostate cancerW G Jones, S D Fosså, L Denis, et al.
Acta Urologica Belgica|January 1, 1980
Hormone therapy in prostatic cancerP H Smith, A Akdas, M K Mason, et al.
British Journal of Urology|October 1, 1982
Bacteraemia resulting from prostatic surgery: the source of bacteriaM R Robinson, S T Arudpragasam, S M Sahgal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials GroupG Stoter, A Akdas, S D Fosså, et al.
Pageof 4